CNMD (CONMED Corporation) Stock Analysis - Analyst Ratings

CONMED Corporation (CNMD) is a publicly traded Healthcare sector company. As of May 21, 2026, CNMD trades at $36.68 with a market cap of $1.10B and a P/E ratio of 24.16. CNMD moved +1.96% today. Year to date, CNMD is -11.63%; over the trailing twelve months it is -38.15%. Its 52-week range spans $33.21 to $78.00. Analyst consensus is neutral with an average price target of $39.24. Rallies surfaces CNMD's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What do analysts rate CNMD?

4 analysts cover CNMD: 0 strong buy, 0 buy, 4 hold, 0 sell, and 0 strong sell. The consensus rating is neutral. The average price target is $39.24.

CNMD Key Metrics

Key financial metrics for CNMD
MetricValue
Price$36.68
Market Cap$1.10B
P/E Ratio24.16
EPS$1.52
Dividend Yield0.20%
52-Week High$78.00
52-Week Low$33.21
Volume70
Avg Volume0
Revenue (TTM)$1.37B
Net Income$47.05M
Gross Margin54.59%

CNMD Analyst Consensus

4 analysts cover CNMD: 0 strong buy, 0 buy, 4 hold, 0 sell, 0 strong sell. Consensus rating is neutral. Average price target: $39.24.

Latest CNMD News

Recent CNMD Insider Trades

  • Glaze Richard sold 257 (~$10.59K) on Nov 21, 2025.
  • Garner Todd W sold 3.50K (~$150.50K) on Nov 6, 2025.
  • Farkas Charles sold 1.10K (~$59.05K) on Sep 12, 2025.

Common questions about CNMD

What do analysts rate CNMD?
4 analysts cover CNMD: 0 strong buy, 0 buy, 4 hold, 0 sell, and 0 strong sell. The consensus rating is neutral. The average price target is $39.24.
Does Rallies show CNMD price targets?
Yes. Rallies tracks CNMD analyst ratings, consensus rating, average price target, upgrades, downgrades, analyst firms, and recent price target changes when available.
Is CNMD research on Rallies investment advice?
No. Rallies provides research, data, and educational context for CNMD. It does not provide personalized investment advice.
CNMD

CNMD